Variants and the future of COVID-19

The future course of the pandemic seems anything but resolved. The emergence of new variants have caused a major reassessment of the trajectory of COVID in 2022 and beyond. What is the likely course of pandemic this autumn and winter? What role could the new highly infectious variants play in transmission, illness and death? Are the current public health measures, radically scaled back in much of the developing world over the course of 2022, appropriate to the risks and challenges COVID currently presents? And what is the next phase of this pathogen likely to be? Are we up collectively to the task of living with endemic COVID? To answer these questions, we discuss with Dr. Eric Topol, a renowned physician, scientist, and author.

“We haven’t put in the effort, the priority, the resources to develop a pan variant vaccine, which would be anticipatory. One thing that’s striking in this entire two and a half years-plus of the pandemic is we’re always chasing, never getting ahead of the virus. We’re smarter than that sucker. […] It’s almost like we’re ignoring the potential there to squash this virus once and for all.”

– Dr. Topol